Phase I/IIA Study of PET Imaging With 89Zr-Df-IAB2M in Metastatic Prostate Cancer
Clinical trial NCT01923727 · COMPLETED
Trial details
- NCT number
- NCT01923727
- Sponsor
- ImaginAb, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-08-01
- Primary completion
- 2016-05-01
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.